AGP Executive Report
Last update: an hour agoCBD Regulation: The EU’s top court ruled that CBD foods cannot carry an organic label without the required authorization, tightening marketing rules for cannabidiol products. Cannabinoid Medicine: MediPharm Labs won a key European regulatory opinion for its metered-dose cannabis inhaler, supporting a possible UK and European launch in 2027, subject to local approvals. Industry Shifts: Elixinol agreed to exit the U.S. and focus on Australian wellness brands, while Cann Group warned that Australia’s medicinal cannabis industry has more production capacity than demand can support. Health Watch: New research linked cannabis use to higher stroke odds, while a separate analysis found cannabis was the substance most often involved in emergency visits among teens and young adults. Market Outlook: Massachusetts voters decisively rejected a measure to end licensed recreational marijuana sales, keeping the state’s regulated market in place.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
